Medtronic plc
AT ˙ WBAG ˙ IE00BTN1Y115
71,24 € ↑1,02 (1,45%)
2026-06-05
DEL PRIS
SecurityAT:MDT / Medtronic plc
InstitutionAddenda Capital Inc.
Latest Disclosed Ownership73,000 shares
Latest Disclosed Value $ 6,377,280
Addenda Capital Inc. ownership in MDT / Medtronic plc

On April 15, 2026 - Addenda Capital Inc. filed a 13F-HR form disclosing ownership of 73,000 shares of Medtronic plc (AT:MDT) valued at $5,412,220 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 73,000 shares of Medtronic plc. This represents a change in shares of 0.00% during the quarter. The current value of the position is $5,200,520 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F MEDTRONIC SHS G5960L103 73,000 0 0.00 6,377 -9.73 0.1796
2026-01-22 2025-12-31 13F MEDTRONIC SHS G5960L103 73,000 -7,977 -9.85 7,064 -9.06 0.2073
2025-10-09 2025-09-30 13F MEDTRONIC SHS G5960L103 80,977 -10 -0.01 7,769 9.16 0.2298
2025-07-17 2025-06-30 13F MEDTRONIC SHS G5960L103 80,987 -487 -0.60 7,117 -3.54 0.2554
2025-04-09 2025-03-31 13F MEDTRONIC SHS G5960L103 81,474 -137 -0.17 7,377 12.40 0.2728
2025-01-16 2024-12-31 13F MEDTRONIC SHS G5960L103 81,611 16,471 25.29 6,564 11.07 0.2317
2024-10-15 2024-09-30 13F MEDTRONIC SHS G5960L103 65,140 12 0.02 5,909 14.27 0.2108
2024-07-16 2024-06-30 13F MEDTRONIC SHS G5960L103 65,128 -19 -0.03 5,171 -9.61 0.2027
2024-04-16 2024-03-31 13F MEDTRONIC SHS G5960L103 65,147 -182 -0.28 5,722 5.44 0.2172
2024-01-23 2023-12-31 13F MEDTRONIC SHS G5960L103 65,329 -67 -0.10 5,426 4.99 0.2120
2023-10-12 2023-09-30 13F MEDTRONIC SHS G5960L103 65,396 -52 -0.08 5,169 -11.07 0.2251
2023-07-21 2023-06-30 13F MEDTRONIC SHS G5960L103 65,448 -24 -0.04 5,811 9.37 0.2439
2023-04-11 2023-03-31 13F MEDTRONIC SHS G5960L103 65,472 14,145 27.56 5,313 32.03 0.2185
2023-01-12 2022-12-31 13F MEDTRONIC SHS G5960L103 51,327 -622 -1.20 4,024 -4.87 0.1747
2022-10-11 2022-09-30 13F MEDTRONIC SHS G5960L103 51,949 51,949 4,230 0.1932
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.